Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 25 February, 2014

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 8913A
GlaxoSmithKline PLC
25 February 2014
 



 

Notification of Transactions of

Directors and Persons Discharging Managerial Responsibility

 

Vesting of conditional share awards made under

the GlaxoSmithKline Share Value Plan

 

This notification sets out the vesting of awards over Ordinary Shares made in 2011 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group.

 

The three-year vesting period for the 2011 SVP awards, which commenced on 24 February 2011, has now ended. The vesting of the SVP awards on 24 February 2014 made to individuals who have subsequently been appointed Persons Discharging Managerial Responsibility (PDMR), are given in the table below.

 

 

Name of PDMR

Number of Ordinary Shares vested

Number of ADS  vested

Mr R Connor

8,230


Mr J Ford


5,740

Mr P Thomson

10,050


Mrs V Whyte

10,050


 

The Company and PDMRs were advised of these transactions on 25 February 2014.

 

The fair market values of an Ordinary Share and of an ADS of GlaxoSmithKline plc at the point of vesting on 24 February 2014 were £16.83 and US$55.75 respectively.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

Sonja Arsenić

Corporate Secretariat

 

25 February 2014


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLELFLZLFLBBX

a d v e r t i s e m e n t